Medicinal products for human use: information on products subject to medical prescription

This dossier concerns information on medicinal products for human use subject to medical prescription. The amendments include rejection of the Commission proposal and provisions maintaining the ban on advertising prescription medicines to the general public while distinguishing advertising from non-promotional information, keeping national competent authorities and health-care professionals as the main sources, and allowing marketing authorisation holders to make available approved summaries of product characteristics and package leaflets, referencing Directive 2001/83/EC.